Skip to main content
. 2016 Aug 26;19(5):579–585. doi: 10.4103/1008-682X.186185

Table 3.

Clinical parameters of prostate cancer patients treated with ADT according to peripheral monocyte count

graphic file with name AJA-19-579-g004.jpg